Cargando…

Retraction: Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6623503/
https://www.ncbi.nlm.nih.gov/pubmed/31295317
http://dx.doi.org/10.1371/journal.pone.0219887
_version_ 1783434181653561344
collection PubMed
description
format Online
Article
Text
id pubmed-6623503
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-66235032019-07-25 Retraction: Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients PLoS One Retraction Public Library of Science 2019-07-11 /pmc/articles/PMC6623503/ /pubmed/31295317 http://dx.doi.org/10.1371/journal.pone.0219887 Text en © 2019 The PLOS ONE Editors http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Retraction
Retraction: Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
title Retraction: Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
title_full Retraction: Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
title_fullStr Retraction: Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
title_full_unstemmed Retraction: Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
title_short Retraction: Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
title_sort retraction: biomarkers for presymptomatic doxorubicin-induced cardiotoxicity in breast cancer patients
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6623503/
https://www.ncbi.nlm.nih.gov/pubmed/31295317
http://dx.doi.org/10.1371/journal.pone.0219887
work_keys_str_mv AT retractionbiomarkersforpresymptomaticdoxorubicininducedcardiotoxicityinbreastcancerpatients